Biotechnology company providing life science researchers easy-to-use, affordable single cell analysis solutions has reported record sales growth for the first half of the fiscal year
Guava Technologies, a biotechnology company providing life science researchers easy-to-use, affordable single cell analysis solutions, has reported record sales growth for the first half of fiscal year 2003.
Revenues for the first six months of 2003 marked the largest two quarters in Guava Technologies's history, up 60% in revenue, 100% in reagent sales, and 55% in the number of systems sold from the same period of 2002.
"Our success this year reflects a strong interest from researchers in the growing list of applications for Guava's personal cell analysis systems," said Rajen Dalal, president and chief executive officer of Guava Technologies.
"First time and repeat customers are discovering that our compact, easy-to-use analysis platform can provide timely, high-quality results that significantly accelerate the pace of their efforts, both in the research lab and in the cell processing facility."
